These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37243125)

  • 1. Developments in Exploring Fungal Secondary Metabolites as Antiviral Compounds and Advances in HIV-1 Inhibitor Screening Assays.
    Nzimande B; Makhwitine JP; Mkhwanazi NP; Ndlovu SI
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses.
    Suwannarach N; Kumla J; Sujarit K; Pattananandecha T; Saenjum C; Lumyong S
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endophytic Fungi as a Source of Antiviral Compounds - A Review.
    Lacerda ÍCDS; Polonio JC; Golias HC
    Chem Biodivers; 2022 Jun; 19(6):e202100971. PubMed ID: 35426966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of small-molecule fungal metabolites in antiviral chemotherapy.
    Roy BG
    Antivir Chem Chemother; 2017 Aug; 25(2):20-52. PubMed ID: 28737040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in the Discovery of Antiviral Metabolites from Fungi.
    Deshmukh SK; Agrawal S; Gupta MK; Patidar RK; Ranjan N
    Curr Pharm Biotechnol; 2022; 23(4):495-537. PubMed ID: 34132180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diversity of anti-microbial secondary metabolites produced by fungal endophytes: an interdisciplinary perspective.
    Mousa WK; Raizada MN
    Front Microbiol; 2013; 4():65. PubMed ID: 23543048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral activity of extracts of basidiomycetes and humic compounds substances against Human Immunodeficiency Virus (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus 1) and Herpes Simplex Virus (Herpesviridae: Simplexvirus: Human alphaherpesvirus 1)].
    Nosik DN; Nosik NN; Teplyakova TV; Lobach OA; Kiseleva IA; Kondrashina NG; Bochkova MS; Ananko GG
    Vopr Virusol; 2020 Nov; 65(5):276-283. PubMed ID: 33533211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endophytic Microbial Diversity: A New Hope for the Production of Novel Anti-tumor and Anti-HIV Agents as Future Therapeutics.
    Banyal A; Thakur V; Thakur R; Kumar P
    Curr Microbiol; 2021 May; 78(5):1699-1717. PubMed ID: 33725144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial Natural Products with Antiviral Activities, Including Anti-SARS-CoV-2: A Review.
    Frediansyah A; Sofyantoro F; Alhumaid S; Al Mutair A; Albayat H; Altaweil HI; Al-Afghani HM; AlRamadhan AA; AlGhazal MR; Turkistani SA; Abuzaid AA; Rabaan AA
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Escape from Small-Molecule Antagonism of Vif.
    Sharkey M; Sharova N; Mohammed I; Huff SE; Kummetha IR; Singh G; Rana TM; Stevenson M
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.
    Hartman TL; Yang L; Helfrick AN; Hassink M; Shank NI; George Rosenker K; Scerba MT; Saha M; Hughes E; Wang AQ; Xu X; Gupta P; Buckheit RW; Appella DH
    Antiviral Res; 2016 Oct; 134():216-225. PubMed ID: 27568924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
    Nakata M; Tang W
    Drug Discov Ther; 2008 Oct; 2(5):262-3. PubMed ID: 22504718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive Secondary Metabolites from Endophytic Fungi.
    Ancheeva E; Daletos G; Proksch P
    Curr Med Chem; 2020; 27(11):1836-1854. PubMed ID: 31526342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Date Palm Trees Root-Derived Endophytes as Fungal Cell Factories for Diverse Bioactive Metabolites.
    Ben Mefteh F; Daoud A; Chenari Bouket A; Thissera B; Kadri Y; Cherif-Silini H; Eshelli M; Alenezi FN; Vallat A; Oszako T; Kadri A; Ros-García JM; Rateb ME; Gharsallah N; Belbahri L
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal endophytes as prolific source of phytochemicals and other bioactive natural products: A review.
    Nisa H; Kamili AN; Nawchoo IA; Shafi S; Shameem N; Bandh SA
    Microb Pathog; 2015 May; 82():50-9. PubMed ID: 25865953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary metabolites produced by endophytic fungi,
    Nzimande B; Kumalo HM; Ndlovu SI; Mkhwanazi NP
    Front Genet; 2022; 13():1077159. PubMed ID: 36583026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals.
    Rice WG; Bader JP
    Adv Pharmacol; 1995; 33():389-438. PubMed ID: 7495676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.